Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2003
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/03/2003EP1367060A1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
12/03/2003EP1367058A1 Tetrahydropyran derivatives
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366150A2 Use of protein histidine phosphatase
12/03/2003EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366063A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancr
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1366049A2 Pirazino[1'2':1,6]pyrido[3,4-b]indole derivatives
12/03/2003EP1366047A1 Thiazole compounds as tgf-beta inhibitors
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/03/2003EP1366030A2 Melanin concentrating hormone receptor ligands
12/03/2003EP1366029A1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents
12/03/2003EP1366025A1 Agonists of beta-adrenoceptors
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366022A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
12/03/2003EP1366020A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1366007A2 Compounds with high monoamine transporter affinity
12/03/2003EP1365841A1 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
12/03/2003EP1365805A2 Novel targeted compositions for diagnostic and therapeutic use
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365798A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
12/03/2003EP1365778A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
12/03/2003EP1365771A1 Method of treating certain eye diseases
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
12/03/2003EP1365760A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1365651A1 Composition and methods for modulation of vascular structure and/or function
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1150963B1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003EP0854715B1 Methods of inhibiting plasminogen activator inhibitor 1
12/03/2003EP0711158B1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460105A 黄嘌呤磷酸二酯酶v抑制剂 Xanthine phosphodiesterase inhibitor v
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1460024A Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1459448A Preparation method of red sageroot total phenolic acid and its use
12/03/2003CN1459303A Kudzu vine flavone capsule, and its prepn. method
12/03/2003CN1459302A Kudzu vine flavone capsule, and its prepn. method
12/03/2003CN1459288A Cyclophosphadenosine glucosamine infusion prepn., and its prepn. process, and method for testing contents thereof
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
12/03/2003CN1129601C Pseudo gensenoside Pgq and its semi synthesis and medicinal use
12/03/2003CN1129599C Substituted benzothiazine/oxazine-2-amide derivatives, their prepn and application
12/03/2003CN1129582C 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
12/03/2003CN1129447C Pill treating cardio cerebral angiopathy
12/03/2003CN1129440C Preparing process for piles treating medicine
12/03/2003CN1129428C Endothelin receptor antagonists
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656729 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656459 Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof
12/02/2003US6656452 Use of inhaled NO as anti-inflammatory agent
12/02/2003CA2287046C Novel dihydroquinoline and tetrahydroquinoline compounds, process for preparing them and pharmaceutical compositions containing them
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
11/2003
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097607A1 Tetrahydroisoquinoline derivatives
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 1595